Added to YB: 2026-09-14
Pitch date: 2026-09-10
ZTS [bullish]
Zoetis Inc.
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$30.3B
Pitch Price
N/A
Price Target
N/A
Dividend
2.89%
EV/EBITDA
9.05
P/E
11.96
EV/Sales
3.98
Sector
Pharmaceuticals
Category
value
Fintwit’s Best Stock Ideas - Zoetis Inc.
ZTS: Zoetis owns half of the global animal-health sector, with a moat built on decades of trust and relationships with veterinarians and difficult-to-replicate drug IP. The shares trade at 12x earnings and cash flow after falling roughly 70% from their all-time high and 50% this year because U.S. vet visits softened. The thesis is that this cyclical weakness will not permanently alter secular trends in pet ownership and animal-health spending.
Read full article (1 min)